Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-09-10 17:52:37 ET · period of report 2026-09-08 · accession 0001193125-26-388156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2026-09-10 17:52 | 2026-09-08 | RVMD | Kim Lorence H. | Dir | S - Sale | $209.82 | -17.1K | 0 | -100% | -$3.59M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-08 | S | D | 706 | $206.60 | 16,384 | I Trust | — | — | (F2) Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026. (F3) The transaction was executed in multiple trades at prices ranging from $206.47 to $206.9903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F4) Shares held by the Lorence Kim Revocable Trust. |
| 2 | Common | Common Stock | 2026-09-08 | S | D | 999 | $207.33 | 15,385 | I Trust | — | — | (F2) Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026. (F5) The transaction was executed in multiple trades at prices ranging from $207.02 to $207.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F4) Shares held by the Lorence Kim Revocable Trust. |
| 3 | Common | Common Stock | 2026-09-08 | S | D | 3,587 | $208.55 | 11,798 | I Trust | — | — | (F2) Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026. (F6) The transaction was executed in multiple trades at prices ranging from $208.05 to $208.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F4) Shares held by the Lorence Kim Revocable Trust. |
| 4 | Common | Common Stock | 2026-09-08 | S | D | 2,853 | $209.56 | 8,945 | I Trust | — | — | (F2) Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026. (F7) The transaction was executed in multiple trades at prices ranging from $209.08 to $209.9809, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F4) Shares held by the Lorence Kim Revocable Trust. |
| 5 | Common | Common Stock | 2026-09-08 | S | D | 4,730 | $210.50 | 4,215 | I Trust | — | — | (F2) Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026. (F8) The transaction was executed in multiple trades at prices ranging from $210.0114 to $210.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F4) Shares held by the Lorence Kim Revocable Trust. |
| 6 | Common | Common Stock | 2026-09-08 | S | D | 3,844 | $211.36 | 371 | I Trust | — | — | (F2) Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026. (F9) The transaction was executed in multiple trades at prices ranging from $211.00 to $211.9425, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F4) Shares held by the Lorence Kim Revocable Trust. |
| 7 | Common | Common Stock | 2026-09-08 | S | D | 371 | $212.27 | 0 | I Trust | — | — | (F2) Transaction made pursuant to a 10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026. (F10) The transaction was executed in multiple trades at prices ranging from $212.0775 to $212.3903, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F4) Shares held by the Lorence Kim Revocable Trust. |